Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company specializing in innovative wellness products, today unveiled the successful results of a controlled efficacy trial (the "Trial") of their diabetic foot relief cream (the "Product").
Related Keywords
Germany , Canada , Canadian , Iris Bincovich , Eva Reuter , Bi Sky Global Ltd , Innocan Pharma Corporation , Trans Epidermal Water Loss , Central Nervous System , Consumer Wellness , Joint Venture , Diabetic Foot , Skin Hydration , Diabetic Complications , Innocan , Skin Dryness , Diabetic Foot Ulcer , Foot Relief ,
comparemela.com © 2020. All Rights Reserved.